WASHINGTON–(ENEWSPF)–February 24 – A consumer watchdog group argued on Wednesday that the recent revelations about the diabetes drug Avandia underscore the need for the strong drug research provisions contained in the health care reform legislation being considered by Congress.
Last Saturday, the Senate Finance Committee issued a report that claims Avandia’s manufacturer, GlaxoSmithKline, knew their drug posed possible heart attack risks for years, but kept that knowledge from the public. (Download Finance Committee report…
